Transfusion Medicine
Vitex reports parasite inactivation results at ISBT 2002
Published in Blood Weekly, October 31st, 2002
At the 27th Congress of the International Society of Blood Transfusion, V.I. Technologies, Inc., (VITX) a biotechnology company dedicated to developing products that improve the safety and availability of the transfusion blood supply by pathogen reduction or removal, reported that its Inactine technology was successful in eradicating the parasites that cause Chagas disease, malaria, and babesiosis in red blood cells.
V.I. Technologies (Vitex) also presented its overall clinical development program for Inactine red blood cells including results of completed clinical trials. Additional study data on the chemistry and safety profile for the Inactine pathogen reduction...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2002-10-31)
More Articles from Blood Weekly
- Blood Products
EVA bags best for transporting frozen blood - Transfusion Medicine
Transfusion decliners usually have low mortality risk - Cardiac Surgery
Routine use of leukodepleted transfusion products offers little benefit - Stem Cell Transplantation
Fractionated TBI-based conditioning enables partially mismatched graft use - Stem Cell Transplantation
High-dose antibiotics can prevent etoposide-related infections - Transplant Medicine
'Killer' cells used to combat rare cancer - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
